Flatiron is a technology platform that provides real-world clinical data collected from the electronic health records (EHRs) used by cancer care providers across the United States. Flatiron data is disease-specific, real-world datasets that enable researchers to monitor and analyze key aspects of the patient journey. These longitudinal, de-identified data sets are sourced from electronic health records (EHRs) deployed at Flatiron’s nationwide network of community oncology practices and academic cancer centers and deliver a wide pool of clinical data including patient demographics, treatment, and clinical outcomes.
Data for 22 diseases is available, including solid tumor clinico-genomic database cohorts that are linked with Foundation Medicine NGS testing. Access to all datasets are via a proposal-based process via Flatiron Explore.
CU Cancer Center investigators can access de-identified data collected on over 3.5 million patients. Curated data sets are made available following submission and approval of a project proposal.
The Cancer Center is supporting the cost of the Flatiron platform, and in partnership with UCHealth is supporting the necessary infrastructure to include UCHealth EMR data into the Flatiron data sets. Individual research projects may incur fees for biostatistician support. The PI will be responsible for any biostatistics fees.
Please visit the Biostatistics and Bioinformatics shared resources page for additional information or email them at CCBiostatistics@cuanschutz.edu.
The Flatiron - UCCC Colorado JSC governs the partnerships between our organizations, oversees key decisions and meets regularly to align on priorities and opportunities. The JSC is made up of CU Cancer Center physician leaders and Flatiron Health representatives.
They champion Flatiron to the larger Cancer Center community, review and approve proposed projects, and ensure resources are allocated to support research using the Flatiron data sets.
Christopher Lieu, MD
Wells Messersmith, MD
Sean Davis, MD, PhD
Linda Cook, PhD
Marcelo Perraillon, PhD